Adar Poonawalla recounts the challenges in producing India’s first COVID vaccine

Poonawalla said he even looked at diluting a stake in Serum from private equity to raise the capital but they didn’t need to do it because they went to other countries and philanthropists instead who understood the urgent need of doing it.